In conclusion, this study employed both human and murine cell lines for in vitro and in vivo experiments, elucidating the role of CYP4F3 in regulating CRC progression, predominantly through regulating NRF2-mediated ferroptosis. Here, NFE2L2 is linked to colorectal carcinoma.